Abstract
Human interferon alpha (IFN-α) was expressed in two strains of Lactococcus lactis by aid of two promoters (P32 and Pnis) giving rise to two recombinant strains: MG:IFN and NZ:IFN, respectively. The expression of IFN was confirmed by ELISA and western blotting. Highest production was achieved using glucose for growth of both recombinant strains with nisin, used for induction of the recombinant strain with Pnis promoter, at 30 ng/ml. The optimum time for MG:IFN was 9 h and for NZ:IFN was 4.5 h. The highest productions by MG:IFN and NZ:IFN were 1.9 and 2.4 μg IFN/l, respectively. Both of the expressed IFNs showed bioactivities of 1.9 × 106 IU/mg that were acceptable for further clinical studies.
Similar content being viewed by others
References
Ayed A, Rabhi I, Dellagi K, Kallel H (2008) High level production and purification of human interferon [alpha] 2b in high cell density culture of Pichia pastoris. Enzyme Microb Technol 42:173–180
Billiau A (2006) Interferon: the pathways of discovery: I. Molecular and cellular aspects. Cytokine Growth Factor Rev 17:381–409
Bosio E, Beilharz MW, Watson MW, Lawson CM (1999) Efficacy of low-dose oral use of type I interferon in cytomegalovirus infections in vivo. J Interferon Cytokine Res 19:869–876
Comabella M, Lünemann J, Rio J, Sanchez A, Lopez C, Julia E, Fernandez M, Nonell L, Camina-Tato M, Deisenhammer F (2009) A type I interferon signature in monocytes is associated with poor response to interferon-β in multiple sclerosis. Brain 132:3353–3365
Holo H, Nes IF (1989) High-frequency transformation, by electroporation, of Lactococcus lactis subsp. cremoris grown with glycine in osmotically stabilized media. Appl Environ Microbiol 55:3119–3123
Ibrahim S, Rahman N, Mohamad R, Rahim R (2010) Effects of agitation speed, temperature, carbon and nitrogen sources on the growth of recombinant Lactococcus lactis NZ9000 carrying domain 1 of aerolysin gene. Afr J Biotechnol 9:5392–5398
Imanaka T, Aiba S (1981) A perspective on the application of genetic engineering: stability of recombinant plasmid. Ann N Y Acad Sci 369:1–14
Mierau I, Kleerebezem M (2005) 10 years of the nisin-controlled gene expression system (NICE) in Lactococcus lactis. Appl Microbiol Biotechnol 68:705–717
Morello E, Bermudez-Humaran L, Llull D, Sole V, Miraglio N, Langella P, Poquet I (2008) Lactococcus lactis, an efficient cell factory for recombinant protein production and secretion. J Mol Microbiol Biotechnol 14:48–58
Noreen N, Hooi WY, Baradaran A, Rosfarizan M, Sieo CC, Rosli MI, Yusoff K, Raha AR (2011) Lactococcus lactis M4, a potential host for the expression of heterologous proteins. Microb Cell Fact 10:28
Ship JA, Fox PC, Michalek JE, Cummins MJ, Richards AB (1999) Treatment of primary sjogren’s syndrome with low-dose natural human interferon-alpha administered by the oral mucosal route: a phase II clinical trial. J Interferon Cytokine Res 19:943–951
Srivastava P, Bhattacharaya P, Pandey G, Mukherjee K (2005) Overexpression and purification of recombinant human interferon alpha2b in Escherichia coli. Protein Expression Purif 41:313–322
Terzaghi BE, Sandine W (1975) Improved medium for lactic streptococci and their bacteriophages. Appl Microbiol 29:807–813
Yu Z, Huang Z, Shao C, Huang Y, Zhang F, Yang J, Deng L, Zeng Z, Deng Q, Zeng W (2011) Oral administration of interferon-a2b-transformed Bifidobacterium longum protects BALB/c mice against coxsackievirus B3-induced myocarditis. Virol J. 8:525
Acknowledgments
We would like to thank the Ministry of Science, Technology and Innovation, Malaysia and Malaysian Genome Institute (MGI) for funding and technical support during the study period. We also thank Kees Leenhouts for the kind gift of plasmids pNZ8048 and pMG36e, and L. lactis hosts NZ9000 and MG1363.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Bayat, O., Baradaran, A., Ariff, A. et al. Intracellular production of IFN-alpha 2b in Lactococcus lactis . Biotechnol Lett 36, 581–585 (2014). https://doi.org/10.1007/s10529-013-1390-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10529-013-1390-4